Accordingly, the pro-steatotic effect of AHR via CYP1A1 activation had been further linked to estrogen metabolism, as estrogen degradation by CYP1A1 diminished the known protective effect of 17β-estradiol (E2) on steatosis [60]. The gene discussed is CYP1A1; the disease is steatosis.